NCT06646913View on ClinicalTrials.gov

TENS in Scleroderma

PHASE1RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

May 31, 2026

Conditions
SclerodermaGastroparesisSystemic Sclerosis (SSc)
Interventions
DEVICE

Transcutaneous Electrical Nerve Stimulation

Patients will utilize the TENS device for 45 minutes, two times per day for the 4 week treatment period.

Trial Locations (1)

48912

RECRUITING

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER